Showing results (241-250 of 395) with videos related to
Sort By:
Pageof 40
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?M M Regan, O Pagani, B Walley, et al.European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VIO Pagani, A O'Neill, M Castiglione, et al.Breast Cancer Research and Treatment|October 23, 2008
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapyMarco Colleoni, Vincenzo Bagnardi, Nicole Rotmensz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2015
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trialE Munzone, A Giobbie-Hurder, B A Gusterson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2012
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group reportP Karlsson, B F Cole, B H Chua, et al.The Lancet. Oncology|October 25, 2011
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-upMeredith M Regan, Patrick Neven, Anita Giobbie-Hurder, et al.Breast (Edinburgh, Scotland)|March 10, 2023
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trialsLaura Pala, Tommaso De Pas, Eleonora Pagan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in SequenceJacquie H Chirgwin, Anita Giobbie-Hurder, Alan S Coates, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2023
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future ResearchFabio Conforti, Laura Pala, Tommaso De Pas, et al.Breast Cancer Research : BCR|November 7, 2012
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IXAlan S Coates, Ewan K A Millar, Sandra A O'Toole, et al.Pageof 40